© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep
Based on recent data, Medicus Pharma Ltd. Common Stock (MDCX) shows an Average True Range (ATR) of 0.2 and an Enterprise Value of N/A. Its average trading volume over the past 3 months is 348.13K, indicating liquidity. These fundamental metrics provide insight into MDCX's underlying financial health and market activity.
Medicus Pharma Ltd. Common Stock (MDCX) technical indicators as of December 22, 2025: the SMA 20 is -12.73%, SMA 50 at -22.61%, and SMA 200 at -42.66%. The RSI 14 value is 37.54, suggesting its current momentum. These technical analysis signals help assess MDCX's price trends and potential future movements.
Medicus Pharma Ltd. Common Stock (MDCX) stock performance overview as of December 22, 2025: The 52-week high is $8.94 (currently -81.1% below), and the 52-week low is $1.59 (currently 5.63% above). Over the past year, MDCX's performance is -38.55%, compared to the S&P 500's 12.87% change.
According to market data, Medicus Pharma Ltd. Common Stock (MDCX) stock's recent performance metrics show that over the last month, MDCX is -21.03%, with a Year-to-Date (YTD) performance of -30.45%. Over the past year, the stock has seen a -38.55% change. These figures summarize MDCX's price movements across various periods, reflecting its historical returns.
According to current financial data, MDCX stock's P/E (TTM) ratio is -2.32, which compares to the S&P 500's P/E of 32.59. The sector median P/E is -1.24. Key valuation ratios for MDCX, including P/S (N/A), P/B (-34.60), and P/FCF (-1.92), offer insights into how the company is valued relative to its earnings, sales, book value, and free cash flow.